Hide Board Information

Show Board Information

Stevia First Corp STVF

Board Mod: geneboyblake

Asst Mods:

Last Post: 07/16/2014 1:06:59 PM

Board Marks: 0

Posts Today: 0

Board Views Today: 6

Stevia First Corp (OTCMRKTS: STVF) Stock Message Board

1. STVF Company Profile

    

2. STVF Time & Sales

    

3. STVF Recent News

    

4. STVF Filings

    

5. STVF Financials

    

6. STVF Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	STVF Financials 07/16/2014 12:07:03 Stevia First	Emylers	07/16/2014 1:06:59 PM
6	$STVF . b	PoemStone	06/18/2014 11:48:53 AM
5	$STVF upturn ga	PoemStone	04/28/2014 11:22:12 AM
4	Latest Stevia First Corp (STVF) Headlines Stevia	Stock_Tracker	03/11/2014 2:01:56 PM
3	STVF 0.47 Stock Charts $STVF 1 Month Chart	chartguy89	03/10/2014 1:54:40 AM
2	STVF Stock Charts Last: +0.005 Saturday, March 1,	chartguy89	03/01/2014 8:26:34 PM
1		geneboyblake	03/05/2013 12:57:22 PM

Recent Articles

• Understanding the TikTok Deal: Implications for ByteDance's Future
• C3.ai Faces Class Action Lawsuit: Key Details for Investors
• Class Action Notice for KinderCare Investors Amid Concerns
• Investors Alert: Participate in Class Action Against SOC Now
• Flywire Corporation Lawsuit Highlights Investor Rights Overview
• ACI Learning Partners with OMREN for Enhanced Cybersecurity Skills
• China World Summit Wing’s Vertical Run: A Community Celebration
• Celebrating the Legacy of the Kashi Fair: A Cultural Journey
• L Catterton's Investment Fuels Seki Furniture's Growth
• Unveiling New Partnerships at the 2025 Media Cooperation Forum
• Cathie Wood's Bold Investment Moves: Key Stock Adjustments
• Snap Inc. Accused of Misleading Statements in Lawsuit
• Wanda L. James Unveils Congressional Campaign for Change
• Qlarant Joins Agile4Vets to Enhance Veteran Healthcare Services
• Qlarant Joins Forces to Transform Veteran Healthcare Services
• Sable Offshore faces investor lawsuit over production claims
• Coty's Stock Troubles: A Deeper Look into Retail Challenges
• AI Startup Born Secures $15 Million to Combat Loneliness
• Elcogen Unveils Cutting-Edge Manufacturing Facility for Clean Energy
• Trailblazer Merger Corporation I Reschedules Annual Meeting
• Understanding the Fluor Corporation Class Action Lawsuit Details
• Explore Artistic Possibilities with Wacom One 14 Pen Display
• Ubiqconn and RuggON Present Innovative Solutions at TADTE
• KT&G Showcases ESSE at Intertabac 2025 to Boost Global Reach
• Investors Concerns Over Fly-E Group, Inc. Amid Class Action
• Understanding Class Action Opportunities for Savara Investors
• Diversified Energy's Secondary Offering: Key Insights Ahead
• Cygnus Metals Boosts Resource Estimate in Copper-Gold Project
• V.F. Corporation Class Action Lawsuit: Key Information for Investors
• Diversified Energy's Recent Ordinary Shares Offering Explained
• Transforming Client Care: Emily Mehr's Role at Sweet James
• Beauty Power's Nail Care Set Wins Prestigious Beauty Award
• Former CIA Officer Discusses AI Project Impact on America
• Elliott Investment Management's Support for Workday's Future
• The Journey of a $1000 Microsoft Investment Over 20 Years
• Clorox Company Announces New Quarterly Dividend of $1.24
• Savara Inc. Investors Get Opportunity for Class Action Suit
• Investors Take Action in Lockheed Martin Securities Case
• Investigation Launch by Rosen Law for Encompass Health Investors
• Elliott Investment Management's Progressive Outlook on Workday
• Landmark Study Highlights NobleStitch™ PFO Closure Benefits
• Nxera Pharma Advances Immunotherapy Research in Cancer Clinical Trial
• Western Forest Products Secures New US$30 Million Credit Facility
• Western Forest Products Secures a New $30 Million Credit Facility
• Discover the Growth Potential of Progressive Investments
• Altimmune Investors Urged to Act Before Class Action Deadline
• Revolutionizing Storytelling: Verily Storyworks Emerges
• Breakthrough Results from ASC30 Study Unveiled at EASD Meeting
• Navigating Opportunities in Recent Sable Offshore Corp. Lawsuit
• Eisai's Etalanetug Tau Antibody Receives FDA Fast Track Status